{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:14:49Z","timestamp":1759342489815,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T00:00:00Z","timestamp":1623024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Ottawa Hospital Academic Medicine Organization","award":["TOH -21 -014"],"award-info":[{"award-number":["TOH -21 -014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Postoperative atrial fibrillation (POAF) is a frequent adverse event after thoracic surgery with associated morbidity, mortality, and healthcare costs. It has been shown to be preventable with prophylactic amiodarone, which is only recommended in high-risk individuals due to the potential associated side effects. Risk factors for POAF have been identified and incorporated into a prediction model to identify high-risk patients. Further evaluation in the form of a multicenter clinical trial is required to assess the effectiveness of prophylaxis specifically in this high-risk population. The feasibility of such a trial first needs to be assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The PREP-AF trial is a double-blind randomized controlled feasibility trial. Individuals undergoing major thoracic surgery who are identified to be high-risk by the POAF prediction model will be randomized 1:1 to receive a short course of amiodarone vs. placebo in the immediate postoperative period. The primary outcome is feasibility, which will be measured by the number of eligible patients identified, consented, and randomized; intervention adherence; and measurement of future outcomes of a full trial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This study will determine the feasibility of a randomized controlled trial to assess the effectiveness of prophylactic amiodarone, in high-risk patients undergoing major thoracic surgery. This will inform the development of a multi-center trial to establish if prophylactic amiodarone is safe and effective at reducing the incidence of POAF. Preventing this adverse event will not only improve outcomes for patients but also reduce the associated health resource utilization and costs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04392921\">NCT04392921<\/jats:ext-link>. Registered on 19 May 2020.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-021-05318-1","type":"journal-article","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T09:05:58Z","timestamp":1623056758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prophylaxis for patients at Risk to Eliminate Post-operative Atrial Fibrillation (PREP-AF trial): a protocol for a feasibility randomized controlled study"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7736-4641","authenticated-orcid":false,"given":"Heather A.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salmaan","family":"Kanji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diem T. T.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calum","family":"Redpath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tori","family":"Lenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Sigler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastien","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Maziak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir","family":"Sundaresan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J. E.","family":"Seely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,7]]},"reference":[{"issue":"3","key":"5318_CR1","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1016\/j.jtcvs.2014.06.036","volume":"148","author":"G Frendl","year":"2014","unstructured":"Frendl G, Sodickson AC, Chung MK, Waldo AL, Gersh BJ, Tisdale JE, et al. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. J Thorac Cardiovasc Surg. 2014;148(3):e153\u201393. https:\/\/doi.org\/10.1016\/j.jtcvs.2014.06.036.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"5318_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.chest.2016.08.1476","volume":"151","author":"B-C Zhao","year":"2017","unstructured":"Zhao B-C, Huang T-Y, Deng Q-W, Liu W-F, Liu J, Deng W-T, et al. Prophylaxis against atrial fibrillation after general thoracic surgery: trial sequential analysis and network meta-analysis. Chest. 2017;151(1):149\u201359. https:\/\/doi.org\/10.1016\/j.chest.2016.08.1476.","journal-title":"Chest"},{"issue":"3","key":"5318_CR3","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.athoracsur.2010.05.014","volume":"90","author":"AJE Seely","year":"2010","unstructured":"Seely AJE, Ivanovic J, Threader J, Al-Hussaini A, Al-Shehab D, Ramsay T, et al. Systematic classification of morbidity and mortality after thoracic surgery. Ann Thorac Surg. 2010;90(3):936\u201342. https:\/\/doi.org\/10.1016\/j.athoracsur.2010.05.014.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"5318_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/ejcts\/ezs085","volume":"42","author":"VP Rao","year":"2012","unstructured":"Rao VP, Addae-Boateng E, Barua A, Martin-Ucar AE, Duffy JP. Age and neo-adjuvant chemotherapy increase the risk of atrial fibrillation following oesophagectomy. Eur J Cardiothorac Surg. 2012;42(3):438\u201343. https:\/\/doi.org\/10.1093\/ejcts\/ezs085.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"5318_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/eurheartj\/ehz431","volume":"41","author":"D Conen","year":"2020","unstructured":"Conen D, Alonso-Coello P, Douketis J, Chan MTV, Kurz A, Sigamani A, et al. Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery. Eur Heart J. 2020;41(5):645\u201351. https:\/\/doi.org\/10.1093\/eurheartj\/ehz431.","journal-title":"Eur Heart J"},{"issue":"4","key":"5318_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/FJC.0000000000000351","volume":"67","author":"L Zhang","year":"2016","unstructured":"Zhang L, Gao S. Systematic review and meta-analysis of atrial fibrillation prophylaxis after lung surgery. J Cardiovasc Pharmacol. 2016;67(4):351\u20137. https:\/\/doi.org\/10.1097\/FJC.0000000000000351.","journal-title":"J Cardiovasc Pharmacol"},{"key":"5318_CR7","doi-asserted-by":"publisher","unstructured":"POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371(9627):1839\u201347. https:\/\/doi.org\/10.1016\/S0140-6736(08)60601-7.","DOI":"10.1016\/S0140-6736(08)60601-7"},{"issue":"6","key":"5318_CR8","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1378\/chest.105.6.1642","volume":"105","author":"W Van Mieghem","year":"1994","unstructured":"Van Mieghem W, Coolen L, Malysse I, Lacquet LM, Deneffe GJ, Demedts MG. Amiodarone and the development of ARDS after lung surgery. Chest. 1994;105(6):1642\u20135. https:\/\/doi.org\/10.1378\/chest.105.6.1642.","journal-title":"Chest"},{"issue":"2","key":"5318_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.athoracsur.2011.12.096","volume":"94","author":"LP Riber","year":"2012","unstructured":"Riber LP, Christensen TD, Jensen HK, Hoejsgaard A, Pilegaard HK. Amiodarone significantly decreases atrial fibrillation in patients undergoing surgery for lung cancer. Ann Thorac Surg. 2012;94(2):339\u201346. https:\/\/doi.org\/10.1016\/j.athoracsur.2011.12.096.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"5318_CR10","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.athoracsur.2009.04.074","volume":"88","author":"JE Tisdale","year":"2009","unstructured":"Tisdale JE, Wroblewski HA, Wall DS, Rieger KM, Hammoud ZT, Young JV, et al. A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection. Ann Thorac Surg. 2009;88(3):886\u201395. https:\/\/doi.org\/10.1016\/j.athoracsur.2009.04.074.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"5318_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jtcvs.2010.01.026","volume":"140","author":"JE Tisdale","year":"2010","unstructured":"Tisdale JE, Wroblewski HA, Wall DS, Rieger KM, Hammoud ZT, Young JV, et al. A randomized, controlled study of amiodarone for prevention of atrial fibrillation after transthoracic esophagectomy. J Thorac Cardiovasc Surg. 2010;140(1):45\u201351. https:\/\/doi.org\/10.1016\/j.jtcvs.2010.01.026.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"5318_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00540-012-1478-3","volume":"27","author":"MA Khalil","year":"2013","unstructured":"Khalil MA, Al-Agaty AE, Ali WG, Azeem MSA. A comparative study between amiodarone and magnesium sulfate as antiarrhythmic agents for prophylaxis against atrial fibrillation following lobectomy. J Anesth. 2013;27(1):56\u201361. https:\/\/doi.org\/10.1007\/s00540-012-1478-3.","journal-title":"J Anesth"},{"issue":"1","key":"5318_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jtcvs.2019.01.095","volume":"158","author":"JE Tisdale","year":"2019","unstructured":"Tisdale JE, Jaynes HA, Watson MR, Corya AL, Shen C, Kesler KA. Amiodarone for prevention of atrial fibrillation following esophagectomy. J Thorac Cardiovasc Surg. 2019;158(1):301\u2013310.e1.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"5318_CR14","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.athoracsur.2011.06.104","volume":"92","author":"HC Fernando","year":"2011","unstructured":"Fernando HC, Jaklitsch MT, Walsh GL, Tisdale JE, Bridges CD, Mitchell JD, et al. The society of thoracic surgeons practice guideline on the prophylaxis and management of atrial fibrillation associated with general thoracic surgery: executive summary. Ann Thorac Surg. 2011;92(3):1144\u201352. https:\/\/doi.org\/10.1016\/j.athoracsur.2011.06.104.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"5318_CR15","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.athoracsur.2004.10.058","volume":"79","author":"RS Passman","year":"2005","unstructured":"Passman RS, Gingold DS, Amar D, Lloyd-Jones D, Bennett CL, Zhang H, et al. Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg. 2005;79(5):1698\u2013703. https:\/\/doi.org\/10.1016\/j.athoracsur.2004.10.058.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"5318_CR16","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.athoracsur.2010.03.100","volume":"90","author":"M Onaitis","year":"2010","unstructured":"Onaitis M, D\u2019Amico T, Zhao Y, O\u2019Brien S, Harpole D. Risk factors for atrial fibrillation after lung cancer surgery: analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database. Ann Thorac Surg. 2010;90(2):368\u201374. https:\/\/doi.org\/10.1016\/j.athoracsur.2010.03.100.","journal-title":"Ann Thorac Surg"},{"key":"5318_CR17","doi-asserted-by":"publisher","unstructured":"Smith H, Li H, Brandts-Longtin O, Yeung C, Maziak D, Gilbert S, et al. External validity of a model to predict postoperative atrial fibrillation after thoracic surgery. Eur J Cardiothorac Surg. https:\/\/doi.org\/10.1093\/ejcts\/ezz341\/5679810 Cited 2020 Jan 18.","DOI":"10.1093\/ejcts\/ezz341\/5679810"},{"issue":"Suppl 4","key":"5318_CR18","first-page":"iv37","volume":"9","author":"E Shantsila","year":"2007","unstructured":"Shantsila E, Watson T, Lip GYH. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias. Europace. 2007;9(Suppl 4):iv37\u201344.","journal-title":"Europace"},{"issue":"3","key":"5318_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/1715163516641136","volume":"149","author":"JE Tisdale","year":"2016","unstructured":"Tisdale JE. Drug-induced QT interval prolongation and torsades de pointes: role of the pharmacist in risk assessment, prevention and management. Can Pharm J. 2016;149(3):139\u201352. https:\/\/doi.org\/10.1177\/1715163516641136.","journal-title":"Can Pharm J"},{"issue":"1","key":"5318_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0735-1097(86)80272-8","volume":"7","author":"V Torres","year":"1986","unstructured":"Torres V, Tepper D, Flowers D, Wynn J, Lam S, Keefe D, et al. QT prolongation and the antiarrhythmic efficacy of amiodarone. J Am Coll Cardiol. 1986;7(1):142\u20137. https:\/\/doi.org\/10.1016\/S0735-1097(86)80272-8.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"5318_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1365-2125.2008.03357.x","volume":"67","author":"H van der Sijs","year":"2009","unstructured":"van der Sijs H, Kowlesar R, Klootwijk APJ, Nelwan SP, Vulto AG, van Gelder T. Clinically relevant QTc prolongation due to overridden drug-drug interaction alerts: a retrospective cohort study. Br J Clin Pharmacol. 2009;67(3):347\u201354. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03357.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"5318_CR22","first-page":"473","volume":"42","author":"M Li","year":"2017","unstructured":"Li M, Ramos LG. Drug-induced QT prolongation and Torsades de Pointes. P T Peer-Rev J Formul Manag. 2017;42(7):473\u20137.","journal-title":"P T Peer-Rev J Formul Manag"},{"issue":"1","key":"5318_CR23","doi-asserted-by":"publisher","first-page":"S3799","DOI":"10.21037\/jtd.2018.09.144","volume":"1","author":"H Smith","year":"2018","unstructured":"Smith H, Yeung C, Gowing S, Sadek M, Maziak D, Gilbert S, et al. A review and analysis of strategies for prediction, prevention and management of post-operative atrial fibrillation after non-cardiac thoracic surgery. J Thorac Dis. 2018;1(1):S3799 -S3808\u2013S3808.","journal-title":"J Thorac Dis"},{"key":"5318_CR24","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE). 2017;155. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_60."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05318-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-021-05318-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05318-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T09:08:45Z","timestamp":1623056925000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-021-05318-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5318"],"URL":"https:\/\/doi.org\/10.1186\/s13063-021-05318-1","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2021,6,7]]},"assertion":[{"value":"13 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ottawa Hospital Research Institute Ethics Review Board approved this study (REB ID 2007862-01H). Written, informed consent to participate will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Willing to provide a model consent form for the proposed trial upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"384"}}